Lipoprotein-associated Phospholipase A2 (Lp-PLA2) Progenitor Cells and Coronary Atherosclerosis in Humans

NCT01067339 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Endothelial Dysfunction

Interventions

DRUG: darapladib
DRUG: placebo

Sponsor

Mayo Clinic

Collaborators

[object Object]
[object Object]
[object Object]